Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1843.4000 -22.10 (-1.18%)
NSE Nov 17, 2026 13:51 PM
Volume: 89,401
 

1843.40
-1.18%
Motilal Oswal
Ipca Laboratories (IPCA) delivered in-line revenue in 4QFY28. It delivered 5% beat on EBITDA, driven by higher gross margin. PAT came in line with estimate.
Ipca Laboratories Ltd. is trading above its 200 day SMA of 1698.8
More from Ipca Laboratories…
All earning calls
Investor presentations from Ipca Laboratories…
All investor presentations